Clinical Trials Browser

Phase 1/2 × Drug Combinations × 1 year × Clear all

NCT07220616 2026-03-18

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Phase 1/2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms